130 related articles for article (PubMed ID: 29614437)
1. Structure-based design, synthesis and evaluation of 2,4-diaminopyrimidine derivatives as novel caspase-1 inhibitors.
Patel S; Modi P; Ranjan V; Chhabria M
Bioorg Chem; 2018 Aug; 78():258-268. PubMed ID: 29614437
[TBL] [Abstract][Full Text] [Related]
2. Design, synthesis and evaluation of 1,2-benzisothiazol-3-one derivatives as potent caspase-3 inhibitors.
Liu D; Tian Z; Yan Z; Wu L; Ma Y; Wang Q; Liu W; Zhou H; Yang C
Bioorg Med Chem; 2013 Jun; 21(11):2960-7. PubMed ID: 23632366
[TBL] [Abstract][Full Text] [Related]
3. Rational approach to identify newer caspase-1 inhibitors using pharmacophore based virtual screening, docking and molecular dynamic simulation studies.
Patel S; Modi P; Chhabria M
J Mol Graph Model; 2018 May; 81():106-115. PubMed ID: 29549805
[TBL] [Abstract][Full Text] [Related]
4. Variation of the aryl substituent on the piperazine ring within the 4-(piperazin-1-yl)-2,6-di(pyrrolidin-1-yl)pyrimidine scaffold unveils potent, non-competitive inhibitors of the inflammatory caspases.
Kent CR; Bryja M; Gustafson HA; Kawarski MY; Lenti G; Pierce EN; Knopp RC; Ceja V; Pati B; Walters DE; Karver CE
Bioorg Med Chem Lett; 2016 Nov; 26(22):5476-5480. PubMed ID: 27777011
[TBL] [Abstract][Full Text] [Related]
5. Exploring the ring potential of 2,4-diaminopyrimidine derivatives towards the identification of novel caspase-1 inhibitors in Alzheimer's disease therapy.
Kumi RO; Soremekun OS; Issahaku AR; Agoni C; Olotu FA; Soliman MES
J Mol Model; 2020 Mar; 26(4):68. PubMed ID: 32130533
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and evaluation of N-acyl-substituted 1,2-benzisothiazol-3-one derivatives as caspase-3 inhibitors.
Li Z; Pan Y; Zhong W; Zhu Y; Zhao Y; Li L; Liu W; Zhou H; Yang C
Bioorg Med Chem; 2014 Dec; 22(24):6735-45. PubMed ID: 25468037
[TBL] [Abstract][Full Text] [Related]
7. Efficient synthesis, biological evaluation, and docking study of isatin based derivatives as caspase inhibitors.
Firoozpour L; Gao L; Moghimi S; Pasalar P; Davoodi J; Wang MW; Rezaei Z; Dadgar A; Yahyavi H; Amanlou M; Foroumadi A
J Enzyme Inhib Med Chem; 2020 Dec; 35(1):1674-1684. PubMed ID: 32842789
[TBL] [Abstract][Full Text] [Related]
8. Design, synthesis and bioevaluation of 2-mercapto-6-phenylpyrimidine-4-carboxylic acid derivatives as potent xanthine oxidase inhibitors.
Shi A; Zhang L; Wang H; Wang S; Yang M; Guan Q; Bao K; Zhang W
Eur J Med Chem; 2018 Jul; 155():590-595. PubMed ID: 29920453
[TBL] [Abstract][Full Text] [Related]
9. The design and synthesis of sulfonamides as caspase-1 inhibitors.
Harter WG; Albrect H; Brady K; Caprathe B; Dunbar J; Gilmore J; Hays S; Kostlan CR; Lunney B; Walker N
Bioorg Med Chem Lett; 2004 Feb; 14(3):809-12. PubMed ID: 14741295
[TBL] [Abstract][Full Text] [Related]
10. 1,2-benzisothiazol-3-one derivatives as a novel class of small-molecule caspase-3 inhibitors.
Wu L; Lu M; Yan Z; Tang X; Sun B; Liu W; Zhou H; Yang C
Bioorg Med Chem; 2014 Apr; 22(8):2416-26. PubMed ID: 24656804
[TBL] [Abstract][Full Text] [Related]
11. Interleukin-1β converting enzyme (ICE): A comprehensive review on discovery and development of caspase-1 inhibitors.
Modi P; Shah BM; Patel S
Eur J Med Chem; 2023 Dec; 261():115861. PubMed ID: 37857145
[TBL] [Abstract][Full Text] [Related]
12. Discovery of 2,4-diaminopyrimidine derivatives targeting p21-activated kinase 4: Biological evaluation and docking studies.
Qin Q; Wu T; Yin W; Sun Y; Zhang X; Wang R; Guo J; Zhao D; Cheng M
Arch Pharm (Weinheim); 2020 Oct; 353(10):e2000097. PubMed ID: 32627873
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and biological evaluation of new pyrimidine-4-yl-ethanol derivatives as ROS1 kinase inhibitors.
Abdelazem AZ; Lee SH
J Enzyme Inhib Med Chem; 2015 Apr; 30(2):290-8. PubMed ID: 24939104
[TBL] [Abstract][Full Text] [Related]
14. Design, synthesis, in vitro Evaluation and docking studies on dihydropyrimidine-based urease inhibitors.
Iftikhar F; Ali Y; Ahmad Kiani F; Fahad Hassan S; Fatima T; Khan A; Niaz B; Hassan A; Latif Ansari F; Rashid U
Bioorg Chem; 2017 Oct; 74():53-65. PubMed ID: 28753459
[TBL] [Abstract][Full Text] [Related]
15. A novel class of small-molecule caspase-3 inhibitors prepared by multicomponent reactions.
Zhu Q; Gao L; Chen Z; Zheng S; Shu H; Li J; Jiang H; Liu S
Eur J Med Chem; 2012 Aug; 54():232-8. PubMed ID: 22652225
[TBL] [Abstract][Full Text] [Related]
16. Applying caspase-1 inhibitors for inflammasome assays in human whole blood.
Lipinska K; Malone KE; Moerland M; Kluft C
J Immunol Methods; 2014 Sep; 411():66-9. PubMed ID: 24925806
[TBL] [Abstract][Full Text] [Related]
17. Protective effect of novel substituted nicotine hydrazide analogues against hypoxic brain injury in neonatal rats via inhibition of caspase.
Deng CB; Li J; Li LY; Sun FJ
Bioorg Med Chem Lett; 2016 Jul; 26(13):3195-3201. PubMed ID: 27216999
[TBL] [Abstract][Full Text] [Related]
18. Rational Drug Design of Topically Administered Caspase 1 Inhibitors for the Treatment of Inflammatory Acne.
Fournier JF; Clary L; Chambon S; Dumais L; Harris CS; Millois C; Pierre R; Talano S; Thoreau É; Aubert J; Aurelly M; Bouix-Peter C; Brethon A; Chantalat L; Christin O; Comino C; El-Bazbouz G; Ghilini AL; Isabet T; Lardy C; Luzy AP; Mathieu C; Mebrouk K; Orfila D; Pascau J; Reverse K; Roche D; Rodeschini V; Hennequin LF
J Med Chem; 2018 May; 61(9):4030-4051. PubMed ID: 29648825
[TBL] [Abstract][Full Text] [Related]
19. Design, synthesis and biological evaluation of pyrimidine-based derivatives as VEGFR-2 tyrosine kinase inhibitors.
Sun W; Hu S; Fang S; Yan H
Bioorg Chem; 2018 Aug; 78():393-405. PubMed ID: 29677483
[TBL] [Abstract][Full Text] [Related]
20. Emodin alleviates intestinal mucosal injury in rats with severe acute pancreatitis via the caspase-1 inhibition.
Ning JW; Zhang Y; Yu MS; Gu ML; Xu J; Usman A; Ji F
Hepatobiliary Pancreat Dis Int; 2017 Aug; 16(4):431-436. PubMed ID: 28823375
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
